Search Results (1,269)

The therapeutic potential of cannabinoids and other ligands of cannabinoid receptors attracts considerable attention due to their diverse pharmacological effects and utility in various medical applications. However, challenges such as low solubility, limited bioavailability, and potential side effects hinder their broad clinical use. Nanoformulation techniques offer a promising approach to address these issues and optimize the therapeutic effectiveness of cannabinoids and other cannabinoid receptor ligands. This comprehensive review explores the advancements in nanoformulation strategies to enhance the therapeutic efficacy and safety of synthetic cannabinoids and related compounds, such as CB13, rimonabant, and HU-211, which have been studied in a range of preclinical models addressing conditions such as neuropathic pain, depression, and cancer. The review discusses various nanocarriers employed in this field, including lipid-based, polymeric, and hybrid nanoparticles, micelles, emulsions, and other nanoengineered carriers. In addition to formulation approaches, this review provides an in-depth analysis of chemical structures and their effect on compound activity, especially in the context of the affinity for the cannabinoid type 1 receptor in the brain, which is chiefly responsible for the psychoactive effects. The provided summary of research concerning either chemical modifications of existing cannabinoids or the creation of new compounds that interact with cannabinoid receptors, followed by the development of nanoformulations for these agents, allows for the identification of new research directions and future perspectives for Cannabis-based medicine. In conclusion, the combination of nanotechnology and cannabinoid pharmacology holds promise for delivering more effective and safer therapeutic solutions for a broad spectrum of medical conditions, making this an exciting area of research with profound implications for the healthcare and pharmaceutical industries. Full article

Cinnamomum camphora (L.) Presl, a perennial evergreen tree of the Lauraceae family, exhibits diverse chemotypes and abundant essential oil constituents, which are widely utilized in pharmaceuticals, perfumery, and fine chemicals. Based on the variation in dominant volatile constituents, five chemotypes have been identified: Borneol Chemotype (BC), Camphor Chemotype (CC), Eucalyptol Chemotype (EC), Isoborneol Chemotype (IC), and Linalool Chemotype (LC). Their compositions of monoterpenoids (MT) and sesquiterpenes (SQT) differ significantly. This review systematically summarizes the research progress on MT and SQT in different chemotypes of C. camphora over the past five decades, with a total of 164 compounds identified (83 MT and 81 SQT), and compares the unique and shared constituents among chemotypes. Pharmacological studies indicate that C. camphora essential oils from different chemotypes exhibit strong antibacterial, anti-inflammatory, and antitumor activities, with linalool, camphor, and several SQT compounds showing remarkable biological effects in multiple bacterial, fungal, and tumor cell models. The underlying mechanisms may involve the disruption of cell membrane integrity, inhibition of key metabolic enzymes, interference with genetic transcription, and synergistic effects among multiple constituents. However, research on low-abundance bioactive components in different chemotypes remains limited, and their pharmacological mechanisms require further elucidation. This review provides a systematic reference for the future exploration of bioactive constituents, mechanistic studies, and efficient utilization of essential oils from different chemotypes of C. camphora, offering valuable insights for refined resource exploitation and industrial application. Full article

Mirabilis expansa root (MER) is an Andean source of starch that could be considered a “lost crop” by the scarcity of its cultivation. Consequently, few studies have reported on its functional properties. To address this gap, we herein analyze and characterize the main components of MER and Mirabilis expansa starch (MES), measuring the water-absorption index (WAI), swelling power (SP), and water solubility index (WSI). We characterized the MES morphological and structural properties by using scanning electron microscopy (SEM). We also examined the starch pasting properties using a Rapid Visco Analyzer (RVA) to determine the peak viscosity (PV), final viscosity (FV), pasting temperature (PT), breakdown (BD), and setback (SB). The thermal properties were determined by differential scanning calorimetry (DSC), the crystallinity by X-ray diffraction, and the molecular structure by Fourier transform infrared spectrometry (FTIR). The main components in the MER and MES were carbohydrates and crude fiber. The MES appeared rich in amylopectin. The functional properties, the WAI, SP, and WSI, were dependent on temperature. The MES showed no morphological changes, a moderate gelatinization temperature, and C-type crystallinity. Finally, the FTIR spectrum presented the typical form for an unmodified starch. Based on these results, Mirabilis expansa may be considered a natural, non-conventional source of starch with potential applications in the food, chemical, and pharmaceutical industries. Full article

Lactobionic acid, widely used in the pharmaceutical, cosmetic, and food industries, is produced through chemical and biological methods, each with distinct advantages and challenges. This review examines the key approaches to its production, highlighting the chemical oxidation of lactose and biotechnological processes using microbial and enzymatic systems. Chemical methods offer high yields and rapid production but are often hindered by environmental concerns and lower product purity. In contrast, biological methods provide eco-friendly alternatives with superior product quality, albeit with limitations in scalability and higher initial costs. The comparison in this overview focuses on productivity, cost efficiency, purity, and environmental impacts, underscoring the potential of biological methods to align with sustainability goals. This review highlights further advances in biological approaches and explores hybrid solutions that combine the strengths of both methods for optimal lactobionic acid production. Full article

With the increasing severity of global water pollution, traditional wastewater treatment methods have gradually revealed limitations in dealing with complex and refractory pollutants. Advanced oxidation processes (AOPs) have emerged as a promising alternative due to their ability to generate highly reactive radicals (such as hydroxyl and sulfate radicals) that can effectively degrade a wide range of pollutants. This review provides a detailed overview of various AOP technologies, including Fenton processes, ozone-based AOPs, persulfate-based AOPs, photocatalytic AOPs, electrochemical AOPs, and sonochemical AOPs, focusing on their fundamental principles, reaction mechanisms, catalyst design, and application performance in treating different types of wastewater. The research results show that the improved Fenton process can achieve a chemical oxygen demand (COD) removal rate of up to 85% when treating pharmaceutical wastewater. Photocatalytic AOP technology demonstrates higher degradation efficiency when treating industrial wastewater containing refractory pollutants. In addition to effectively degrading refractory pollutants and reducing dependence on traditional biological treatment methods, these advanced oxidation processes can also significantly reduce secondary pollution generated during the treatment process. Moreover, by optimizing AOP technologies, the deep mineralization of harmful substances in wastewater can be achieved, reducing the potential pollution risks to groundwater and soil while also lowering energy consumption during the treatment process. Additionally, this review discusses the challenges faced by AOPs in practical applications, such as high energy consumption, insufficient catalyst stability, and secondary pollution. This review summarizes the research progress and application trends of catalytically driven AOPs in the field of wastewater treatment over the past five years. It aims to provide a comprehensive reference for researchers and engineering professionals on the application of AOPs in wastewater treatment, promoting the further development and practical implementation of these technologies. Full article

Widespread antibiotic residues are accumulating in the environment, potentially causing adverse effects for humans, animals, and the ecosystem, including an increase in antibiotic-resistant bacteria, resulting in worldwide concern. There are various commonly used physical, chemical, and biological treatments for the degradation of antibiotics. However, the elimination of toxic end products generated by physicochemical methods and the need for industrial applications pose significant challenges. Hence, environmentally sustainable, green, and readily available approaches for the transformation and degradation of these antibiotic compounds are being sought. Herein, we review the impact of sustainable fungal laccase-based bioremediation strategies. Fungal laccase enzyme is considered one of the most active enzymes for biotransformation and biodegradation of antibiotic residue in vitro. For industrial applications, the low laccase yields in natural and genetically modified hosts may constitute a bottleneck. Methods to screen for high-laccase-producing sources, optimizing cultivation conditions, and identifying key genes and metabolites involved in extracellular laccase activity are reviewed. These include advanced transcriptomics, proteomics, and metagenomics technologies, as well as diverse laccase-immobilization technologies with different inert carrier/support materials improving enzyme performance whilst shifting from experimental assays to in situ monitoring of residual toxicity. Still, more basic and applied research on laccase-mediated bioremediation of pharmaceuticals, especially antibiotics that are recalcitrant and prevalent, is needed. Full article

The Caco-2 in vitro model of the intestinal barrier is a well-established system for the investigation of the intestinal fate of orally ingested chemicals and drugs, and it has been used for over ten years by pharmaceutical industries as a model for absorption in preclinical studies. The Caco-2 model shows a fair correlation with in vivo drug absorption, though some inherent biases remain unresolved. Its main limitation lies in the lack of structural complexity, as it does not replicate the diverse cell types and mucus layer present in the human intestinal epithelium. Consequently, the development of advanced in vitro models of the intestinal barrier, that more structurally resemble the human intestinal epithelium physiology, has increased the potential applications of these models. Recently, Caco-2-based advanced intestinal models have proven effective in predicting nanomaterial uptake and transport across the intestinal barrier. The aim of this review is to provide a state-of-the-art of human in vitro intestinal barrier models for the study of translocation/uptake of nanoparticles relevant for oral exposure, including inorganic nanomaterials, micro/nano plastic, and fiber nanomaterials. The main effects of the above-mentioned nanomaterials on the intestinal barrier are also reported. Full article

The genus Colletotrichum is widely known for its phytopathological significance, especially as the causative agent of anthracnose in diverse agricultural crops. However, recent studies have unveiled its ecological versatility and biotechnological potential, particularly among endophytic species. These fungi, which asymptomatically colonize plant tissues, stand out as high-yielding producers of bioactive secondary metabolites. Given their scientific and economic relevance, this review critically examines endophytic Colletotrichum species, focusing on the chemical diversity and biological activities of the metabolites they produce, including antibacterial, antifungal, and cytotoxic activity against cancer cells, and antioxidant properties. This integrative review was conducted through a structured search of scientific databases, from which 39 relevant studies were selected, highlighting the chemical and functional diversity of these compounds. The analyzed literature emphasizes their potential applications in pharmaceutical, agricultural, and industrial sectors. Collectively, these findings reinforce the promising biotechnological potential of Colletotrichum endophytes not only as sources of bioactive metabolites but also as agents involved in ecological regulation, plant health promotion, and sustainable production systems. Full article

The pharmaceutical industry faces significant challenges when promising drug candidates fail during development due to suboptimal ADME (absorption, distribution, metabolism, excretion) properties or toxicity concerns. Natural compounds are subject to the same pharmacokinetic considerations. In silico approaches offer a compelling advantage—they eliminate the need for physical samples and laboratory facilities, while providing rapid and cost-effective alternatives to expensive and time-consuming experimental testing. Computational methods can often effectively address common challenges associated with natural compounds, such as chemical instability and poor solubility. Through a review of the relevant scientific literature, we present a comprehensive analysis of in silico methods and tools used for ADME prediction, specifically examining their application to natural compounds. Whereas we focus on identifying the predominant computational approaches applicable to natural compounds, these tools were developed for conventional drug discovery and are of general use. We examine an array of computational approaches for evaluating natural compounds, including fundamental methods like quantum mechanics calculations, molecular docking, and pharmacophore modeling, as well as more complex techniques such as QSAR analysis, molecular dynamics simulations, and PBPK modeling. Full article

Lactic acid (LA) is a high-value chemical with growing demand for the production of polymers and plastics and in the food and pharmaceutical industries. However, production costs remain a significant constraint when using conventional food-grade substrates. This study investigates Ivorian sugarcane molasses, an abundant agro-industrial by-product, as a low-cost carbon source for LA production via batch fermentation with Limosilactobacillus fermentum ATCC 9338. Molasses was pretreated by acid hydrolysis to improve fermentability, increasing glucose and fructose concentrations. Comparative fermentations using raw and pretreated molasses showed a 75% increase in LA production (32.4 ± 0.03 g/L) after pretreatment. Optimisation using Box–Behnken design revealed that the initial sugar concentration, inoculation rate, and stirring speed significantly influenced lactic acid production. Under optimal conditions, a maximum LA concentration of 52.4 ± 0.49 g/L was achieved with a yield of 0.95 g/g and productivity of 0.73 g/L·h. Kinetic analysis confirmed efficient sugar utilisation under the optimised conditions, and polarimetry revealed a near-racemic lactic acid. A simplified cost analysis showed that molasses could reduce carbon source costs by over 70% compared to refined sugars, supporting its economic viability. This work demonstrates the potential of pretreated molasses under robust fermentation conditions as a sustainable and cost-effective substrate for LA production in resource-limited contexts. The approach aligns with circular bioeconomy principles and presents a replicable model for decentralised bioproduction in a developing country like Côte d’Ivoire. Full article

The shikimate pathway is the fundamental metabolic route for aromatic amino acid biosynthesis in bacteria, plants, and fungi, but is absent in mammals. This review explores how multi-enzyme synergy and allosteric regulation coordinate metabolic flux through this pathway by focusing on three key enzymes: 3-deoxy-d-arabino-heptulosonate-7-phosphate synthase, chorismate mutase, and tryptophan synthase. We examine the structural diversity and distribution of these enzymes across evolutionary domains, highlighting conserved catalytic mechanisms alongside species-specific regulatory adaptations. The review covers directed evolution strategies that have transformed naturally regulated enzymes into standalone biocatalysts with enhanced activity and expanded substrate scope, enabling synthesis of non-canonical amino acids and complex organic molecules. Industrial applications demonstrate the pathway’s potential for sustainable production of pharmaceuticals, polymer precursors, and specialty chemicals through engineered microbial platforms. Additionally, we discuss the therapeutic potential of inhibitors targeting pathogenic organisms, particularly their mechanisms of action and antimicrobial efficacy. This comprehensive review establishes the shikimate pathway as a paradigmatic system where understanding allosteric networks enables the rational design of biocatalytic platforms, providing blueprints for biotechnological innovation and demonstrating how evolutionary constraints can be overcome through protein engineering to create superior industrial biocatalysts. Full article

Edible mushrooms are well-known for their culinary and nutritional values. Additionally, they serve as a natural source of polyphenols, a group of bioactive compounds that significantly treat diseases associated with oxidative stress. The polyphenolic profile of mushrooms mainly consists of phenolic acids and flavonoids, whose chemical properties have attracted the attention of both the food and pharmaceutical industries. Consequently, methods for extracting polyphenols from mushrooms encompass conventional techniques (maceration and Soxhlet extraction) as well as innovative or green methods (ultrasound-assisted extraction, microwave-assisted extraction, pressurized liquid extraction, supercritical fluid extraction, enzyme-assisted extraction, and pulsed electric field extraction). Nonetheless, extraction with pressurized liquids and supercritical fluids is considered the most suitable method, as they function in a gentle and selective manner, preserving the integrity of the phenolic compounds. The use of mushroom-derived phenolic compounds in food and pharmaceutical formulations continues to face challenges concerning the safety of these extracts, as they might contain unwanted substances. Future applications should incorporate purification systems to yield highly pure extracts, thereby creating safe polyphenol carriers (for food and pharmaceutical products) for consumers. Full article

The resulting plant waste from R. idaeus, P. serotina, P. avium, and P. cerasus exhibits a complex chemical composition, depending on the variety from which it originates, with applications in multiple fields such as the food, pharmaceutical or dermato-cosmetic industry due to the presence of phytochemical compounds such as flavonoids, flavonols, tannins, cyanogenic glycosides, vitamins, aldehyde, and phenolic acids. The aim of this review was to summarize and analyze the most recent and significant data from literature on the importance of plant waste resulting from the pruning process of trees and shrubs, in the context of applying circular economy principles, with a focus on the pharmacological importance (antimicrobial, antioxidant, anti-inflammatory, anticoagulant, antiviral, and antitumoral) of some bioactive compounds identified in these species. Their applicability in various industries is closely linked to both the bioavailability of the final products and the study of their toxicity. The literature indicates that the isolation of these compounds can be carried out using conventional or modern methods, the last ones being favored due to the increased efficiency of the processes, as well as from the perspective of environmental protection. This review increases the attention and perspective of using plant waste as a linked source of pharmaceutical and dermato-cosmetic agents. Full article

Isatis tinctoria L. (Brassicaceae), also known as woad or dyer’s woad, is an ancient plant with a rosy future ahead. Most of the knowledge about woad is related to indigo dye production and its medicinal applications, especially its leaves. The general interest in woad has decreased with the rise of petroleum-based products. However, nowadays this plant is attracting interest again with industries reintroducing natural dyes. To meet the market demand in a sustainable manner, recent studies have focused specifically on woad seeds, leading to a valorization of the whole woad plant. This review provides an overview of the botanical, phytochemical composition, and properties of woad seeds, primarily supporting their cosmetic and pharmaceutical potential. From a chemical point of view, woad seeds mainly contain fatty acids, amino acids, phytosterols and glucosinolates. These compounds have been investigated through their extraction and analytical methods, as well as their properties and industrial applications. Full article

Xylanase is an essential industrial enzyme for degrading plant biomass, pulp and paper, textiles, bio-scouring, food, animal feed, biorefinery, chemicals, and pharmaceutical industries. Despite its significant industrial importance, the extensive application of xylanase is hampered by high production costs and concerns regarding the safety of xylanase-producing microorganisms. The utilisation of renewable polymers for enzyme production is becoming a cost-effective alternative. Among the prospective candidates, non-pathogenic lactic acid bacteria (LAB) are promising for safe and eco-friendly applications. Our investigation revealed that Pediococcus pentosaceus G4, isolated from plant sources, is a notable producer of extracellular xylanase. Improving the production of extracellular xylanase is crucial for viable industrial applications. Therefore, the current study investigated the impact of various medium components and optimised the selected medium composition for extracellular xylanase production of P. pentosaceus G4 using Plackett–Burman Design (PBD) and Central Composite Design (CCD) statistical approaches. According to BPD analysis, 8 out of the 19 investigated factors (glucose, almond shell, peanut shell, walnut shell, malt extract, xylan, urea, and magnesium sulphate) demonstrated significant positive effects on extracellular xylanase production of P. pentosaceus G4. Among them, glucose, almond shells, peanut shells, urea, and magnesium sulphate were identified as the main medium components that significantly (p < 0.05) influenced the production of extracellular xylanase of P. pentosaceus G4. The optimal concentrations of glucose, almond shells, peanut shells, urea, and magnesium sulphate, as determined via CCD, were 26.87 g/L, 16 g/L, 30 g/L, 2.85 g/L, and 0.10 g/L, respectively. The optimised concentrations resulted in extracellular xylanase activity of 2.765 U/mg, which was similar to the predicted extracellular xylanase activity of 2.737 U/mg. The CCD-optimised medium yielded a 3.13-fold enhancement in specific extracellular xylanase activity and a 7.99-fold decrease in production costs compared to the commercial de Man, Rogosa and Sharpe medium, implying that the CCD-optimised medium is a cost-effective medium for extracellular xylanase production of P. pentosaceus G4. Moreover, this study demonstrated a positive correlation between extracellular xylanase production, growth, lactic acid production and the amount of sugar utilised, implying the multifaceted interactions of the physiological variables affecting extracellular xylanase production in P. pentosaceus G4. In conclusion, statistical methods are effective in rapidly assessing and optimising the medium composition to enhance extracellular xylanase production of P. pentosaceus G4. Furthermore, the findings of this study highlighted the potential of using LAB as a cost-effective producer of extracellular xylanase enzymes using optimised renewable polymers, offering insights into the future use of LAB in producing hemicellulolytic enzymes. Full article